Fortrea Holdings (FTRE) Change in Account Payables (2022 - 2026)

Fortrea Holdings (FTRE) reported Change in Account Payables of $41.3 million for Q1 2026, up 245.42% on a YoY basis from $12.0 million in Q1 2025, and up 304.46% quarter-over-quarter from -$20.2 million in Q4 2025.

Fortrea Holdings (FTRE) Change in Account Payables (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Change in Account Payables for 5 years, with the latest figure at $41.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables rose 245.42% year-over-year to $41.3 million; the trailing twelve-month figure through Mar 2026 stood at -$40.2 million (down 98.03% YoY), and the FY2025 full-year result was -$109.9 million, down 1626.39% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $41.3 million, up from -$20.2 million in the prior quarter.
  • The five-year high for Change in Account Payables was $41.3 million in Q1 2026, with the low at -$42.9 million in Q3 2025.
  • Historically, Change in Account Payables has averaged -$120000.0 across 5 years, with a median of $1.3 million in 2022.
  • Annual changes were most pronounced in 2024 — Change in Account Payables soared 2880.0% — and 2025, when it sank 3055.56%.
  • Fortrea Holdings' Change in Account Payables stood at $1.3 million in 2022, then soared by 623.08% to $9.4 million in 2023, then slumped by 85.11% to $1.4 million in 2024, then plunged by 1542.86% to -$20.2 million in 2025, then soared by 304.46% to $41.3 million in 2026.
  • The last three Change in Account Payables figures came in at $41.3 million (Q1 2026), -$20.2 million (Q4 2025), and -$42.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -3.26 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 35.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -9.42 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 41.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 41.30 Mn
Mar 31, 2026 41.30 Mn
Dec 31, 2025 -20.20 Mn
Dec 31, 2025 -20.20 Mn
Sep 30, 2025 -42.90 Mn
Sep 30, 2025 -42.90 Mn
Jun 30, 2025 -18.40 Mn
Jun 30, 2025 -18.40 Mn
Mar 31, 2025 -28.40 Mn
Mar 31, 2025 -28.40 Mn
Dec 31, 2024 1.40 Mn
Dec 31, 2024 1.40 Mn
Sep 30, 2024 -7.20 Mn
Sep 30, 2024 -7.20 Mn
Jun 30, 2024 13.90 Mn
Jun 30, 2024 13.90 Mn
Mar 31, 2024 -900,000.00
Mar 31, 2024 -900,000.00
Dec 31, 2023 9.40 Mn
Dec 31, 2023 9.40 Mn